← All trials
NCT03028129
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2017
- Primary completion
- Jun 1, 2019
- Completion date
- Jun 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 728
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Federal University of Mato Grosso do SulLead sponsor
- Federal University of Mato Grosso do SulReponsible party - principal investigator
- Oswaldo Cruz FoundationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.